Emerald Clinical

Overview

Emerald Clinical is a full-service global clinical research organization (CRO) combining deep scientific insight with operational excellence. Headquartered in Singapore, the organization leverages Asia-Pacific heritage with global teams across China, EMEA, and the Americas to accelerate clinical development across multiple therapeutic areas.

Therapeutic Expertise

Renal Research: Positioned as the world leader in renal research with an extensive site network and over 100 renal studies conducted across 70+ countries. Scientific leadership guided by world-renowned renal experts, paired with proven operational excellence and consistently high recruitment and retention rates.

Oncology: Accelerates recruitment and patient engagement with experience across 106,000+ participants enrolled across 2,200+ sites worldwide. Offers services from Australian Early Phase to global Phase III with oncology-specialized teams ensuring scientific integrity and operational excellence.

Cardiovascular: Advances global health through efficient, high-quality cardiovascular trials with comprehensive end-to-end services. Expanding cardiovascular team guided by multidisciplinary clinician and researcher KOLs with deep regional insights across global populations.

Early-Phase Research: Dedicated early-phase capabilities supporting concept-to-conclusion development.

Core Services

• Clinical trial management and site management
• Patient recruitment and retention
• Study design and protocol development
• Clinical monitoring and data integrity
• Safety and pharmacovigilance services
• Regulatory consulting and navigation
• Medical writing
• Data management and biostatistics
• Endpoint adjudication

Global Reach

Operates across 40+ locations with dedicated teams serving 70+ countries via strategic partnerships. Engages 700,000+ patients worldwide and serves 15 of the top 20 pharmaceutical firms plus 160+ biotech companies.